Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS4898592 A
Publication typeGrant
Application numberUS 07/245,923
Publication dateFeb 6, 1990
Filing dateSep 16, 1988
Priority dateAug 23, 1986
Fee statusLapsed
Also published asEP0258521A1, EP0258521B1, US4994049
Publication number07245923, 245923, US 4898592 A, US 4898592A, US-A-4898592, US4898592 A, US4898592A
InventorsArno W. Latzke, Ralf Latzke, Gert Latzke
Original AssigneeLatzke Arno W, Ralf Latzke, Gert Latzke
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Means for the application of transdermally absorbable active substances
US 4898592 A
Abstract
A device for the application of heated transdermally absorbable active substances has a carrier impregnated with a transdermally absorbable active substance and a support. The support is a laminate made up of one or more polymeric layers and optionally includes a heat conductive element. A preferred mode of carrier attachment involves the use of a magnetic connector.
Images(4)
Previous page
Next page
Claims(22)
What is claimed is:
1. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 2 to 6 mm, said first foam layer including a foil-facing area and a laminate-contacting area defined on a first surface, and an opposite surface,
(b) a second closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said second foam layer including a laminate-contacting surface bonded to said laminate-contacting area of the first foam layer and an opposite, skin-contacting surface, wherein at least one portion of said second foam layer has been removed to define pink-shaped side walls housing the carrier, and
(c) a flexible heat-conductive metal foil, said metal foil including a first surface facing said foil-contacting surface of the first foam layer and an opposite surface facing said carrier.
2. A device according to claim 1, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
3. A device according to claim 1, wherein the skin-contacting surface of said second foam layer is covered with a skin-compatible fabric.
4. A device according to claim 1, wherein the support is in the shape of a headband.
5. A device according to claim 1, wherein the support is in the shape of a pad.
6. A device according to claim 1, wherein the skin-contacting surface of the second foam layer is surface texturized.
7. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 1 to 5 mm, said first foam layer including a foil-bonding surface and an opposite surface,
(b) a flexible heat-conductive metal foil including a surface bonded to said foil-bonding surface of the first foam layer, and an opposite surface,
(c) a second closed-cell polyethylene foam layer having a thickness of 1 to 4 mm, said second foam layer including a surface bonded to said opposite surface of the metal foil, and an opposite surface, and
(d) a third closed-cell polyethylene foam layer having a thickness of 1 to 4 mm, said third foam layer including a laminate-contacting surface bonded to said opposite surface of the second foam layer and an opposite, skin-contacting surface, wherein at least one portion of said third foam layer has been removed to define side walls surrounding an area housing the carrier, the size of the housing area being equal to or slightly larger than the surface area of the carrier.
8. A device according to claim 7, wherein said side walls define a pinked shape.
9. A device according to claim 7, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
10. A device according to claim 7, wherein the support is in the shape of a headband.
11. A device according to claim 7, wherein the support is in the shape of a pad.
12. A device according to claim 7, wherein the skin-contacting surface of said third foam layer is covered with a skin-compatible fabric.
13. A device according to claim 7, further comprising a multiple interlocking hook-and-loop type fastener attaching said carrier to said support, said fastener including one side attached to a non-skin-contacting, support-facing surface of the carrier and an opposing side, interlocking with said one side, attached to an area of the opposite surface of the second foam layer facing the carrier, said area of the opposite surface of the second foam layer defining a bottom wall covering the housing area.
14. A device according to claim 7, wherein the skin-contacting surface of the third foam layer is surface texturized.
15. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said first foam layer including a foil-bonding surface and an opposite surface,
(b) a flexible heat-conductive metal foil including a surface bonded to said foil-bonding surface of the first foam layer, and an opposite surface,
(c) a second closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said second foam layer including a laminate-contacting surface bonded to said opposite surface of the foil and an opposite, skin-contacting surface, wherein at least one portion of said second foam layer has been removed to define side walls surrounding an area housing the carrier, the size of the housing area being equal to or slightly larger than the surface area of the carrier.
16. A device according to claim 15, wherein said side walls define a pinked shaped.
17. A device according to claim 15, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
18. A device according to claim 15, wherein the support is in the shape of a headband.
19. A device according to claim 15, wherein the support is in the shape of a pad.
20. A device according to claim 15, wherein the skin-contacting surface of said second foam layer is covered with a skin-compatible fabric.
21. A device according to claim 15, further comprising a multiple interlocking hook-and-loop type fastener attaching said carrier to said support, said fastener including one side attached to a non-skin-contacting, support-facing surface of the carrier and an opposing side, interlocking with said one side, attached to an area of the opposite surface of the second foam layer facing the carrier, said area of the opposite surface of the second foam layer defining a bottom wall covering the housing area.
22. A device according to claim 15, wherein the skin-contacting surface of the second foam layer is surface texturized.
Description

This application is a continuation of U.S. application Ser. No. 042,344, filed Apr. 24, 1987, now abandoned.

The present invention relates to a device for the application of transdermally absorbable active substances which allows an intensive and sustained action of the transdermally absorbable active substances over a long period of time and increases the efficiency thereof by simultaneous action of heat.

BACKGROUND OF THE INVENTION

A number of pains, cramps and convulsive disorders are caused by an insufficient or non-uniform blood flow in the outer skin. In many cases alleviation, improvement or even healing may be achieved by a uniform application of heat. The treatment with infrared radiation, warming bottles, heating pads, hot packs and cataplasms always involves considerable trouble and therefore is not always or readily practicable.

It is also known that transdermally absorbable active substances such as, more specifically, oils of officinal herbs, are therapeutically active, particularly when they can display their action over a sufficiently long period of time and have the opportunity of penetrating into the skin. There has already been a long search for possibilities of enhancing the efficiency of the transdermally absorbable active substances.

From the EP-A- 0 0163 045 there are known means for heat insulation and distribution, more specifically of heat of the body, on areas of the outer skin which means consist of a laminate comprising a foam layer, a flexible heat-conducting metal layer and a further foam layer. These means have already proven to be valuable in the form of warming plasters, pads, mats etc.

SUMMARY OF THE INVENTION

It is the object of the present invention to combine said principle of heat therapy with the principle of the application of transdermally absorbable active substances, more specifically of oils from officinal herbs, in order to enhance and optimize the therapeutic activity.

Surprisingly, that object can be effectively and readily attained using means for the application of transdermally absorbable active substances, which means consist of at least one replaceable carrier (1) impregnated with the transdermally absorbable active substances and a support (2) for the carrier consisting of a laminate comprising

(a) a closed-cell polyethylene foam layer (3`) having a thickness of 1 to 5 mm,

(b) a flexible heat-conductive metal foil (4),

(c) a closed-cell polyethylene foam layer (5) having a thickness of 1 to 4 mm, which may optionally be colored,

(d) a closed-cell polyethylene foam layer (6) having a thickness of 1 to 4 mm, which may optionally be surface texturizing, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or

(a) a closed-cell polyethylene foam layer (3) having a thickness of 2 to 5 mm,

(b) a flexible heat-conductive metal foil (4),

(c) a closed-cell polyethylene foam layer (6) having a thickness of 2 to 5 mm, which may optionally be surface texturized, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or

(a) a closed-cell polyethylene foam layer (3) having a thickness of 2 to 6 mm, which may optionally be colored,

(b) a closed-cell polyethylene foam layer (6) having a thickness of 2 to 5 mm, which may optionally be surface texturized, from which at least one portion (7), preferably in pinked shape, has been punched, the absorptive carrier (1) on one side being firmly bonded to a flexible heat-conductive metal foil (4).

DETAILED DESCRIPTION

To allow easier attachment to the body, the means preferably have a fabric layer (8) on the foam layer (3), which preferably consists of Borsched nylon. This fabric layer allows the means of the invention to be attached to the body by use of skin-compatible self-adhesive plasters or elastic bandages having Velcro or interlocking hook-and-loop type fastners strip fasteners.

The device of the invention may be manufactured in the form of plasters, head-bands or pads, with head-bands and pads comprising several punched pieces (7) and carriers (1) impregnated with transdermally absorbable active substances and replaceably inserted therein.

As the carriers (1) there may preferably be used nonwoven fabrics and, more specifically, any skin-compatible random laid nonwoven fabric having a sufficient rigidity which can be impregnated with the transdermally absorbable active ingredients. However, basically any other sufficiently rigid skin-compatible absorptive carriers which are resistant to transdermally absorbable active substances such as, open-cell foams, fabric etc. may be used. The shape of said impregnated carriers may be selected as desired and, for example, be square, rectangular or polygonal. Particularly simple and preferred is the circular shape. These carriers impregnated with transdermally absorbable active substances either may be freshly prepared by the user or may be supplied sealed in a bag--like refreshment cloths--from the manufacturer.

The size of the punched pieces (7) is equal in area or slightly larger than that of the carrier (1) and is preferrably pinked. This shape provides a good support of the carrier in the recess and, in addition, favors the formation of air chambers at the margin of the carrier in which vapors of the transdermally absorbable substance may accumulate.

The closed-cell polyethylene foam layers (3), (5) and (6) may vary in thickness within the ranges as indicated between 1 and 5 mm or 1 and 6 mm, respectively, while the laminate altogether should be between 5 and 12 mm, and preferably between 6 and 10 mm, in thickness. Thinner laminates are difficult to manufacture and do not provide sufficient storage of heat. Thicker laminates will be too rigid and unhandy and too bulky.

As the flexible heat-conductive metal foil there is mainly used aluminum foil which is preferably 20 to 50 micrometers in thickness.

In a simpler embodiment preferred for manufacturing, the foam layer (5) is omitted, so that the carrier (1) has direct contact with the metal foil (4). This may result in even a more rapid and higher warming of the carrier (1) and, thus, the effect is induced more rapidly and is stronger.

It is also possible to omit the metal film (4) in the support laminate (2) altogether, if the absorptive carrier on one side is firmly bonded to the flexible heatconductive metal foil (4). In this embodiment, it is preferred that the two remaining foam layers (3) and (6) are different in color. Furthermore, in this embodiment, more specifically the layer (3) is selected so that it is thicker and/or made of a foam having coarser pores which has a higher heat insulation capacity.

The astonishing high efficiency of the invention device is due to the following mechanism of action: As is the case with the means according to EP-A 0 163 045, the total laminate of the support (2) causes a good storage and distribution of the body heat to be effected. It has been shown that the feedback of heat to the body is particularly high in the punched portion (7). It is exactly this location where the carrier (1) impregnated with the transdermally absorbable active substances is situated, so that the transdermally absorbable active substances are warmed to a particularly high degree. This results in an increase of the vapor pressure of the transdermally absorbable active ingredients and an increased activity thereof in the area of the punched portions (7). In the air chambers close to the margin of the carrier the vapors of the transdermally absorbable active ingredients can accumulate so that they can display their activities over an extended period of time. The metal foil (4) acts at the same time as a baffle and prevents the vapors from prematurely escaping through the foam.

As it is preferred that the foam layer (6) contiguous to the skin is surface texturizing, some partial aeration and ventilation takes place so that an undesired sweat formation is suppressed. Due to this surface texturizing, a portion of the vapors of the transdermally absorbable active substance can display their effects beyond the punching area. Thus, the surface texturizing preferably is in a square pattern spaced 1 to 3 mm apart. The grooves may be about 0.5 to 2 mm in depth. Instead of surface texturizing, it is also possible to laminate the layer (6) with a fabric layer.

Measurements of the skin temperature under the action of the device of the invention have resulted in the finding that strongest heating occurs at the margins of the carrier (1), namely in the aeration chambers. This result can be explained only by the fact that at said location there is a minimum heat insulation so that the heat collected around the support (2) can be passed back to the body relatively undisturbed and at these locations the vapors of the transdermally absorbable active substances can act on the skin at a relatively high concentration.

In the manufacture of the support (2), there basically exists a possibility of integrally making the polyethylene foam layers (5) and (6), or (4) and (6), or even (3) and (6), respectively, and then therefrom to punch the portion (7) in such a manner that still up to 4 mm of the foam layer can remain between the support (1) and the metal foil (4). However, from the standpoint of manufacturing engineering such a procedure will be substantially more difficult than to laminate the respective two partial layers to each other as set forth hereinabove. This has another advantage in that the foam layers (5) and/or (3), respectively, may be colored, so that the punched portion (7) becomes clearly visible. This facilitates inserting the carrier (1) into the punched portion. Instead of punching said portion; (7), it is of course also possible to hot-emboss said portion which procedure, however, will hardly produce sharper pinks. In order to effect an improved attachment of the carrier (1) to the support (2), an impact adhesive or a double-sided adhesive film may be employed.

After the application, the carriers (1) will be discarded in most of the cases, whereas the support (2) may frequently be re-used. It may also be washed at 30 C. and thereby be kept in hygienic conditions.

The transdermally absorbable active substances may include, for example, liquids such as oils, but also tablets, pastes and powders if they have a sufficiently high vapor pressure. More particularly, oils of medicinal herbs may be employed. The preferred oils of medicinal herbs include ethereal oils such as camphor oil, green oil, lavender oil, peppermint oil, rosemary oil and turpentine oil as well as mixtures thereof. These oils are administered under condition of long-term warming for a therapeutic treatment of muscle and joint pain, lumbago, sciatica, intervertebral disk and rheumatic problems. They may further be employed for the prophylaxis and after-treatment of sports injuries, strains and contusions. In all these cases there is an increase in the tissue metabolism and an improved blood flow. Thus, the means of the invention constitute an excellent applicator, more specifically for medicinal oils and their vapors, whereby the efficiency is intensified and prolonged.

When the means according to the invention were tested, it was found that, particularly upon repeated use of the support, the carriers are no longer sufficiently supported and tend to come loose or displaced from their pre-determined positions. Although, basically, the carrier may be attached to the support by an impact adhesive or a piece of double-sided adhesive film, the following additional fastening means have proven to be better suitable. Velcro strip fasteners (13) are attached to the surface facing the support (2) of the carrier (1) as well as to the surface facing the carrier (1). A preferred embodiment consists of a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) attached to the surface facing the support (2) of the carrier (1), and in the support (2) there is attached facing the carrier a magnetic foil (11), which has been alternatingly positively and negatively permanently magnetized in the form of stripes, the distance of the magnetized bands from one another being between 3 and 10 mm.

The reversible attachment using a Velcro strip fastener is relatively simple and inexpensive to effect. However, the Velcro strip fastener has the drawback of that it is rather bulky and, thus, results in an undesired bulging of the device of the invention. Thus, one will accept this drawback only for devices in which a higher total thickness is acceptable.

The attachment using a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) has been shown to be particularly advantageous, since these metal fastening means may be readily attached to the surface facing the support (2) of the carrier (1), which is the surface remote from the body surface. This may be effected, for example, by interbonding with the nonwoven material or adhesion bonding thereto. In the embodiment in which the absorbable carrier (1) is on one side firmly bonded to the flexible heat-conductive metal foil (4), it is possible to insert the metal plate (9) or the metal wire (10) between the carrier and the metal foil.

As the magnetically adhesive metal plate or magnetically adhesive metal wire there may be used in particular iron, but also other ferromagnetic alloy or metals. When iron or steel is employed, it may be expedient, for reasons of protection from corrosion, to use iron plates or iron wires the surfaces of which have been zinc-plated or otherwise protected from corrosion.

As the magnetic foils, which have been alternatingly positively and negatively permanently magnetized in stripe form and wherein the distance of the magnetized stripes from one another is between 3 and 10 mm, there are suitable commercially available magnetic foils which are supplied in thicknesses of between 0.5 and 2 mm, and preferably between 1.0 and 1.5 mm, and have been alternatingly magnetized in the desired manner. The stripes may be linear or circular so that the magnetic stripes are arranged as concentric rings.

The distance of the magnetized stripes of between 3 and 10 mm ensures a good adhesion of the metal plates or of the metal wire to be effected due to magnetic attraction, even if they are not close to each other. This is due to the fact that stripe-shaped magnetic foils alternatingly positively and negatively permanently magnetized produce a sufficiently strong magnetic field even at a distance of some millimeters.

The size of the plate (9) may be larger or smaller than the size of the magnetic foil (11). It is preferred that the size of the magnetic plate is of the same order of magnitude as the punched portion (7). Using larger magnetic foils requires higher technical and material expenses. Magnetic foils (11) too small in dimensions fail to ensure a sufficient magnetic attraction of the metal plate (9) or of the metal wire (10).

Although it would basically be possible to interchange the positions of metal plate (9) or of metal wire (10), respectively, with the position of the magnetic foil (11), this would in fact mean that the carrier, only used once, would be disposed of together with the relatively expensive magnetic foil, whereas in the claimed embodiment the magnetic foil can be used several times together with the support (2).

It has also been shown that in some cases it may be advantageous in the device of the invention to cover the surface of the support (2) facing the skin with a skin-compatible material (12). To this purpose, it is preferred to laminate a thin cotton fabric or an otherwise skin-compatible fabric with a pre-fabricated adhesive layer such as, for example, the product Mefix of the firm Molnlycke.

Preferred embodiments of the means according to the invention for the application of transdermally absorbable active substances are shown in the Figures of the attached drawing.

FIG. 1 shows a top plan view of the means in the shape of a plaster.

FIG. 2 shows a sectional view of these means.

FIG. 3 and FIG. 4 show sectional views of simplified embodiments.

FIG. 5, FIG. 6 and FIG. 7 show embodiments derived from those according to the FIGS. 2, 3 and 4, wherein additional metal plates and magnetic foils have been incorporated for attaching the carrier to the support.

FIG. 8 shows a top plan view of a carrier (1) comprising a magnetically adhesive metal wire net.

FIG. 9 shows an embodiment similar to FIG. 2, including an additional skin compatible layer and Velcro fasteners.

FIG. 10 shows the device of the present invention in the shape of a headband.

In the Figures, like parts have been designated by like reference numerals which have the following meanings:

(1) a carrier impregnated with a transdermally absorbable active substance;

(2) the entire support;

(3) a closed-cell polyethylene foam layer;

(4) a flexible heat-conductive metal foil;

(5) a closed-cell polyethylene foam layer which may optionally be colored;

(6) a closed-cell polyethylene foam layer which may optionally be surface texturized or laminated with a fabric;

(7) a portion punched in pinked shape;

(8) a fabric layer made of Borsched nylon;

(9) a magnetically adhesive metal plate;

(10) a magnetically adhesive metal wire;

(11) a magnetic foil which, in stripe form, has been alternatingly positively and negatively permanently magnetized, the distance of the magnetized stripes from one another being between 3 and 10 mm;

(12) a skin compatible layer; and

(13) Velcro interlocking hook-and-loop type fasteners.

In this preferred embodiment according to FIG. 2 the thickness of the polyethylene foam layer (3) is about 2 mm, the thickness of the polyethylene foam layer (5) is about 3 mm, and the thickness of the polyethylene foam layer (6) in original state is also 2 mm, and 1 to 1.8 mm in the surface texturizing state. Hence, the depth of the punched portion (7) is also about 1.8 mm. In the embodiments according to the FIGS. 3 and 4 the foam layers usually are somewhat thicker.

The removable and replaceable, skin-compatible plaster or the elastic bandage having a Velcro strip fastener for attaching the device of the invention to the skin have not been shown. Due to the fabric layer (8) which preferably consists of Borsched nylon, the self-adhesive plasters as well as the Velcro strip fasteners will adhere sufficiently firmly, while they may be removed again without any damage to the support (2), so that this support (2) may be frequently re-used.

The punched portion (7) according to FIG. 1 is pinked in such a manner that saw-tooth-shaped aeration chambers are formed. Together with the inlaid carrier there is formed the image of flower leaves or of the aureole of a sun. However, basically there may be used linear or even wavily curved dents and, thus, rounded dents may be employed, if they are capable of sufficiently supporting the carrier (1) impregnated with the transdermally absorbable active substances.

For the manufacture of an appropriate head band, a longitudinally extended support 5 to 30 cm in length and 2 to 4 cm in width is prepared wherein one or more portions (7) have been punched and into which appropriate smaller carriers (1) may be inserted. For the manufacture of pads, on the other hand, larger dimensions are chosen and also several portions (7) are punched into which appropriately larger carriers (1) may be inserted.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1862122 *Oct 3, 1929Jun 7, 1932Schrader William LPlaster and package therefor
US2344021 *Sep 5, 1942Mar 14, 1944George BouzianeSurgical bandage
US3026874 *Nov 6, 1959Mar 27, 1962Robert C StevensWound shield
US3598122 *Apr 1, 1969Nov 23, 1982 Title not available
US3674027 *Aug 6, 1969Jul 4, 1972Raul FleischmajerDisposable wet compresses
US3777754 *Nov 13, 1972Dec 11, 1973Plachy WMedicated disposable pad
US3837340 *Jun 4, 1973Sep 24, 1974Lilly Co EliDevice for administering immunication against virus
US4230105 *Nov 13, 1978Oct 28, 1980Merck & Co., Inc.Transdermal delivery of drugs
US4286592 *Feb 4, 1980Sep 1, 1981Alza CorporationTherapeutic system for administering drugs to the skin
US4297995 *Jun 3, 1980Nov 3, 1981Key Pharmaceuticals, Inc.Bandage containing attachment post
US4460372 *Apr 1, 1983Jul 17, 1984Alza CorporationPercutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4564010 *Apr 18, 1984Jan 14, 1986Daubert Coated Products Inc.Pressure sensitive adhesive film for medical use
US4592753 *Nov 28, 1983Jun 3, 1986Elan Corporation P.L.C.Drug delivery device
US4595391 *Jan 10, 1984Jun 17, 1986George AbplanalpOintment applicator
US4605399 *Dec 4, 1984Aug 12, 1986Complex, Inc.Transdermal infusion device
US4695277 *Aug 16, 1985Sep 22, 1987Allpack Industrielle Lohnverpackung Gmbh & Co. KgPharmaceutical adhesive plaster and method for manufacturing it
US4710191 *Dec 16, 1985Dec 1, 1987Jonergin, Inc.Therapeutic device for the administration of medicaments
US4765986 *Jun 17, 1986Aug 23, 1988Liedtke Pharmed GmbhMedicinal plaster for systemic use
DE2301821A1 *Jan 15, 1973Aug 1, 1974Georg HubmannMedicinal mud pack with high thermal storage - obtd. by reflective and insulating outer facing, pref. contained in tear off protective casing
DE2722273A1 *May 17, 1977Nov 30, 1978Klaus HomannRheumatic plaster construction - has a thin layer of foam to give thermal insulation and heat retention
EP0136393A1 *Feb 8, 1984Apr 10, 1985Lacotherm AgMagnetic sheets
FR2561505A1 * Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4994049 *Nov 15, 1989Feb 19, 1991Latzke Arno WDevice for applying a substance to the skin
US5531670 *Jan 17, 1992Jul 2, 1996Anette DoblougHeat conserving bandage
US5658583 *Jul 28, 1995Aug 19, 1997Zhang; JieApparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5730721 *Jan 25, 1996Mar 24, 1998Vesture CorporationMedical applicator and method
US5919479 *Mar 18, 1997Jul 6, 1999Zars, Inc.Noninvasive dermal anesthetics
US6245347Sep 29, 1998Jun 12, 2001Zars, Inc.Methods and apparatus for improved administration of pharmaceutically active compounds
US6261595Feb 29, 2000Jul 17, 2001Zars, Inc.Transdermal drug patch with attached pocket for controlled heating device
US6284266Sep 29, 1998Sep 4, 2001Zars, Inc.Methods and apparatus for improved administration of fentanyl and sufentanil
US6303142Apr 7, 2000Oct 16, 2001Zars, Inc.Methods and apparatus for improved administration of pharmaceutically active compounds
US6306431Apr 7, 2000Oct 23, 2001Zars, Inc.Apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US6340472Apr 7, 2000Jan 22, 2002Zars, Inc.Method for reducing onset time of pharmaceutically active compounds
US6453648Jul 6, 1999Sep 24, 2002Zars, Inc.Method for manufacturing a heat generating apparatus
US6465006Apr 7, 2000Oct 15, 2002Zars, Inc.Method for facilitating absorption of pharmaceutically active compounds
US6488959May 24, 2001Dec 3, 2002Zars, Inc.Transdermal drug patch with attached pocket for controlled heating device
US6546281May 24, 1999Apr 8, 2003Zars, Inc.Integrated apparatus for controlled heat aided dermal drug delivery
US6613350Apr 7, 2000Sep 2, 2003Zars, Inc.Electrical apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US6726673May 24, 1999Apr 27, 2004Zars, Inc.Methods and apparatus for improved administration of testosterone pharmaceuticals
US6780426Nov 27, 2002Aug 24, 2004Zars, Inc.Method and apparatus for improved heat controlled administration of pharmaceuticals
US6890553Jul 7, 2000May 10, 2005Johnson & Johnson Consumer Companies, Inc.Exothermic topical delivery device
US6955819Feb 28, 2001Oct 18, 2005Zars, Inc.Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
US7083839Dec 20, 2001Aug 1, 2006Kimberly-Clark Worldwide, Inc.Laminate structures containing activatable materials
US7988742 *Oct 25, 2004Aug 2, 2011Celeste Ann SteinArt wrap bandage
US8409133Dec 18, 2008Apr 2, 2013Insuline Medical Ltd.Drug delivery device with sensor for closed-loop operation
US8622991Mar 19, 2008Jan 7, 2014Insuline Medical Ltd.Method and device for drug delivery
US8827979Mar 19, 2008Sep 9, 2014Insuline Medical Ltd.Drug delivery device
US8961458Nov 6, 2009Feb 24, 2015Insuline Medical Ltd.Device and method for drug delivery
US9012477Jan 5, 2010Apr 21, 2015Nuvo Research Inc.Method of treating neuropathic pain
US9056167Mar 19, 2013Jun 16, 2015Insuline Medical Ltd.Method and device for drug delivery
US9186273May 4, 2010Nov 17, 2015Nuvo Research Inc.Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
US9186334Mar 16, 2011Nov 17, 2015Nuvo Research Inc.Heat assisted lidocaine and tetracaine for transdermal analgesia
US9220837Jun 21, 2007Dec 29, 2015Insuline Medical Ltd.Method and device for drug delivery
US20030118779 *Dec 20, 2001Jun 26, 2003Kimberly-Clark Worlwide, Inc.Activatable laminate structures
US20030138464 *Nov 27, 2002Jul 24, 2003Jie ZhangMethod and apparatus for improved heat controlled administration of pharmaceuticals
US20030219470 *Dec 4, 2002Nov 27, 2003Jie ZhangElectrical apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US20040071760 *Jan 7, 2002Apr 15, 2004Israel DvoretzkyTherapeutic film forming composition and treatment system therefor
US20040265353 *May 28, 2004Dec 30, 2004Zars, Inc.Systems and methods for treating panic attacks
US20060078600 *Feb 3, 2004Apr 13, 2006Lts Lohmann Therapie-Systeme AgTransdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
US20060088686 *Oct 25, 2004Apr 27, 2006Stein Celeste AArt wrap bandage
US20080281297 *Jun 21, 2007Nov 13, 2008Benny PesachMethod and device for drug delivery
US20080299182 *Feb 29, 2008Dec 4, 2008Shuyuan ZhangMethods and formulations for topical gene therapy
US20100152644 *Mar 19, 2008Jun 17, 2010Insuline Medical Ltd.Method and device for drug delivery
US20100174225 *Mar 19, 2008Jul 8, 2010Benny PesachDrug delivery device
US20100286467 *Mar 19, 2008Nov 11, 2010Benny PesachDevice for drug delivery and associated connections thereto
US20110015229 *Jan 5, 2010Jan 20, 2011Jie ZhangMethod of treating neuropathic pain
US20110086913 *Apr 1, 2010Apr 14, 2011Jie ZhangMethods for treating myofascial, muscle, and/or back pain
US20110112189 *May 12, 2011Jie ZhangMethods of treating pains associated with neuroma, nerve entrapment, and other conditions
CN1899644BSep 29, 1999Dec 12, 2012沙斯公司Methods and apparatus for improved administration of pharmaceutically active compounds
CN100402001CSep 15, 1999Jul 16, 2008沙斯公司Methods and apparatus for improved administration of fentanyl and supentanil
CN100515418CJul 26, 1996Jul 22, 2009扎尔斯股份有限公司Methods and apparatus for improved administration of analgesics
DE10058323A1 *Nov 24, 2000Jun 6, 2002Seifert Heinz JuergenBandage contains devices which emit field and medically active material, side applied to skin being porous and opposite side gas- and liquid-impermeable
EP2279713A2Jul 26, 1996Feb 2, 2011Zars, Inc.Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
WO1991013677A1 *Mar 6, 1991Sep 19, 1991Shettigar U RamakrishnaAutologous blood recovery membrane system and method
WO1997004728A1 *Jul 26, 1996Feb 13, 1997Zars, Inc.Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
WO2000018338A1 *Sep 15, 1999Apr 6, 2000Zars, Inc.Methods and apparatus for improved administration of fentanyl and sufentanil
WO2000018339A1 *Sep 29, 1999Apr 6, 2000Zars, Inc.Methods and apparatus for improved administration of pharmaceutically active compounds
WO2001003619A1Jul 7, 2000Jan 18, 2001Johnson & Johnson Consumer Companies, Inc.Exothermic topical delivery device
Classifications
U.S. Classification604/307, 424/448, 424/449, 602/46
International ClassificationA61M35/00, A61F7/02, A61L15/44, A61K9/70
Cooperative ClassificationA61F2007/0001, A61K9/703, A61F7/02, A61F2007/0261, A61F2007/0217
European ClassificationA61F7/02, A61K9/70E2
Legal Events
DateCodeEventDescription
Nov 15, 1993REMIMaintenance fee reminder mailed
Feb 6, 1994LAPSLapse for failure to pay maintenance fees
Apr 19, 1994FPExpired due to failure to pay maintenance fee
Effective date: 19930206